Patent 7494650 was granted and assigned to Galaxy Biotech on February, 2009 by the United States Patent and Trademark Office.
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.